Innovating Works

ELANA®

Financiado
Bypassing open heart surgery with Excimer Laser Assisted Non Occlusive Anastomos...
Bypassing open heart surgery with Excimer Laser Assisted Non Occlusive Anastomosis (ELANA®) We will revolutionise the medical field by replacing expensive, invasive and high-risk open-heart surgery, with keyhole minimally invasive surgery (MIS) to treat coronary artery disease (CAD). Our ELANA® technology enables reprodu... We will revolutionise the medical field by replacing expensive, invasive and high-risk open-heart surgery, with keyhole minimally invasive surgery (MIS) to treat coronary artery disease (CAD). Our ELANA® technology enables reproducible coronary artery bypass grafting (CABG) surgery without the need of heart arrest and suturing, thus avoiding the need to open the patient’s chest. This is realised with an innovative clip which circumvents the need of suturing of blood vessels altogether. By realising closed-chest CABG, ELANA® reduces not only the risks associated with traditional CABG, such as bleeding, stroke and wound infection, but also significantly shortens recovery times. As a result, ELANA® will reduce direct healthcare costs of CABG procedures by over 50%. To critically de-risk our technological development and accelerate market entry to 2025, AMT Medical seeks a total of €7.5M funding (€2.5M grant, €5M equity) to finalise clinical validation and gain market approval. ver más
30/09/2024
4M€
Duración del proyecto: 24 meses Fecha Inicio: 2022-09-29
Fecha Fin: 2024-09-30

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-09-30
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 4M€
Líder del proyecto
AMT MEDICAL RESEARCH BV No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5